Skip to main content

Table 3 Pharmacokinetic properties of the selected molecules capsaicin, rosamarinic acid and resveratrol

From: In silico profiling of nonsynonymous SNPs of fat mass and obesity-associated gene: possible impacts on the treatment of non-alcoholic fatty liver disease

Molecules

GI absorption

BBB permeant

Pgp substrate

CYP1A2 inhibitor

CYP2C19 inhibitor

CYP2C9 inhibitor

CYP2D6 inhibitor

CYP3A4 inhibitor

log Kp (cm/s)

Capsaicin

High

Yes

No

Yes

No

No

Yes

Yes

-5.62

Rosamarinic acid

Low

No

No

No

No

No

No

No

-6.82

Resveratrol

High

Yes

No

Yes

No

Yes

No

Yes

-5.47